End the Adderall Shortage by Urging the DEA & FDA to Lift Manufacturing Quotas

The Issue

The nation-wide Adderall shortage has had serious effects on many ADHD patients’ ability to function in their daily lives. Providers have begun switching patients to alternative medications for ADHD, though alternatives and lesser known brand generics do not work as well as the originally prescribed medication for most since quality and efficacy among brands vary. 

The shortages of Adderall and related medications have made it difficult for patients to manage  their attention deficit hyperactivity disorder (ADHD), and have created immense hardship for parents  of children with ADHD. The Adderall Shortage has caused Adult ADHD patients to lose their jobs, carry out activities of daily living, and unable to manage or properly care for their children who are likely to have ADHD as well. Children are suffering in school, causing lower performance in academics and an increase in behavioral and emotional problems because they can no longer perform or function while consistently medicated with the ADHD meds they've taken for years. Patients who are without their ADHD meds are experiencing harmful withdrawal symptoms, including severe depression. 

Especially concerning are reports that desperate patients have died after turning to counterfeit  pills laced with fentanyl and an increase in the use of illegal stimulant drugs like cocaine or methamphetamines in a desperate attempt to find focus and concentration. 

Due to the rise in telehealth access during covid-19 and the millions of long-covid sufferers experiencing brain fog, prescriptions for Adderall increased 15% over the past year. Despite the demand, DEA Acting Administrator Amne Milgram and the FDA refuse to lift or adjust production quotas for controlled  substances used to treat ADHD to ensure manufacturers have sufficient quota to meet surges in demand for the Adderall that Americans suffering with ADHD need to manage their careers, education, and every day lives.. 

Please sign this petition to urge Anne Milgram and the DEA to Lift annual production Quotas of Adderall to meet the demand so adults can resume managing their ives and give children the medication they need to manage their behaviors and academic success. 

1,183

The Issue

The nation-wide Adderall shortage has had serious effects on many ADHD patients’ ability to function in their daily lives. Providers have begun switching patients to alternative medications for ADHD, though alternatives and lesser known brand generics do not work as well as the originally prescribed medication for most since quality and efficacy among brands vary. 

The shortages of Adderall and related medications have made it difficult for patients to manage  their attention deficit hyperactivity disorder (ADHD), and have created immense hardship for parents  of children with ADHD. The Adderall Shortage has caused Adult ADHD patients to lose their jobs, carry out activities of daily living, and unable to manage or properly care for their children who are likely to have ADHD as well. Children are suffering in school, causing lower performance in academics and an increase in behavioral and emotional problems because they can no longer perform or function while consistently medicated with the ADHD meds they've taken for years. Patients who are without their ADHD meds are experiencing harmful withdrawal symptoms, including severe depression. 

Especially concerning are reports that desperate patients have died after turning to counterfeit  pills laced with fentanyl and an increase in the use of illegal stimulant drugs like cocaine or methamphetamines in a desperate attempt to find focus and concentration. 

Due to the rise in telehealth access during covid-19 and the millions of long-covid sufferers experiencing brain fog, prescriptions for Adderall increased 15% over the past year. Despite the demand, DEA Acting Administrator Amne Milgram and the FDA refuse to lift or adjust production quotas for controlled  substances used to treat ADHD to ensure manufacturers have sufficient quota to meet surges in demand for the Adderall that Americans suffering with ADHD need to manage their careers, education, and every day lives.. 

Please sign this petition to urge Anne Milgram and the DEA to Lift annual production Quotas of Adderall to meet the demand so adults can resume managing their ives and give children the medication they need to manage their behaviors and academic success. 

The Decision Makers

Anne Milgram
Anne Milgram
Acting Administrator of the Drug Enforcement Administration
Louis J. Milione
Louis J. Milione
Deputy Administrator

Supporter Voices

Petition Updates